The Airways Inflammation Group at the University of Calgary in the Snyder Institute for Chronic Diseases is involved in numerous research areas targeting aspects of Asthma and COPD for which current therapies are less than ideal. The group is well positioned to study these complex diseases from a number of different perspectives, including studies of inflammatory mechanisms, surfactant function, airway remodeling, and epithelial cell biology, and can test pharmacological interventions in both pre-clinical and clinical settings. This research has been facilitated by the recent opening of a new ~1500 square foot "state-of-the-art" dedicated clinical research suite that is unique in Canada. The group is made up of basic and clinician scientists who are well published and recognized worldwide in their areas of expertise. The collaborative atmosphere within the group promotes a team effort to elucidating the underlying mechanisms of these diseases and finding better therapeutics for combating these ailments.
The research group has the capacity to conduct studies at all levels from cell cultures to clinical trials.
Model systems include:
A) In Vitro Models: Cultures and Co-Cultures
Have initiated co-culture models for epithelial-fibroblast or epithelial-SMC interactions.
Group members also have experience with a variety of other cell types, including macrophages, dendritic cells, neutrophils, eosinophils and mast cells.
B) Animal Models
C) Human Studies
There are full facilities for nasal and pulmonary provocation studies, bronchoscopy (lavage/brushing/biopsy), sputum induction, pulmonary function (spirometry & plethysmography), exhaled nitric oxide measurements and exercise testing.
Dr. David Proud (Group's Chair)
Tel: (403) 210-3816
Fax: (403) 270-0692